Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
Cancer Research UK
Turning Point Therapeutics, Inc.
Novartis
Shenzhen BinDeBio Ltd.
INSYS Therapeutics Inc
Case Comprehensive Cancer Center